Farrerol Alleviates Hypoxic-Ischemic Encephalopathy by Inhibiting Ferroptosis in Neonatal Rats Via the Nrf2 Pathway

Overview

Journal Physiol Res

Specialty Physiology

Date 2023 Oct 5

PMID 37795893

Authors

Y Li

T Wang

P Sun

W Zhu

Y Chen

M Chen

X Yang

X Du

Y Zhao

Affiliations

Soon will be listed here.

Abstract

Farrerol (FA) is a traditional Chinese herbal medicine known for its anti-inflammatory and anti-oxidative properties in various diseases. Ferroptosis is an iron-dependent oxidative stress-induced cell death. It is characterized by lipid peroxidation and glutathione depletion and is involved in neuronal injury. However, the role of FA in inhibiting ferroptosis in hypoxic-ischemic encephalopathy (HIE) and its underlying mechanisms are not yet completely elucidated. This study aimed to investigate whether FA could mediate ferroptosis and explore its function and molecular mechanism in HIE. A neonatal rat model of HIE was used, and rats were treated with FA, ML385 (a specific inhibitor of nuclear factor erythroid 2-related factor 2 [Nrf2]), or a combination of both. Neurological deficits, infarction volume, brain water content, pathological changes, and iron ion accumulation in the brain tissues were measured using the Zea-Longa scoring system and triphenyl tetrazolium chloride (TTC), hematoxylin-eosin (HE), and Perls' staining. The expression levels of GSH-Px, MDA, SOD, and ROS in brain tissues were also evaluated. Western blot analysis was performed to analyze the expression of the Nrf2 pathway and ferroptosis-related proteins. The results showed that FA administration significantly reduced neuronal damage, infarct volume, cerebral edema, and iron ion accumulation and inhibited MDA and ROS levels while promoting GSH-Px and SOD levels. FA also increased the expression levels of glutathione peroxidase 4 (GPX4), solute carrier family 7 member 11 (SLC7A11), Nrf2, and HO-1. Moreover, the combination of ML385 and FA in HIE abolished the FA protective effects. Therefore, the study concludes that FA exerts a neuroprotective effect after HIE by inhibiting oxidative stress and ferroptosis via the Nrf2 signaling pathway.

Citing Articles

Echinocystic acid ameliorates ischemic acute kidney injury in neonatal rats by attenuating ferroptosis via the Nrf2/GPX4 pathway.

Dang X, Zhang Q, Jiang X, Hu X Immunol Res. 2025; 73(1):58.

PMID: 40067558 DOI: 10.1007/s12026-025-09613-w.

Beyond Mortality: Exploring the Influence of Plant Phenolics on Modulating Ferroptosis-A Systematic Review.

Zivanovic N, Lesjak M, Simin N, Srai S Antioxidants (Basel). 2024; 13(3).

PMID: 38539867 PMC: 10968245. DOI: 10.3390/antiox13030334.

A ferroptosis-related ceRNA network for investigating the molecular mechanisms and the treatment of neonatal hypoxic-ischemic encephalopathy.

Lu H, Shen H, Mao L, Mussap M, Song L Transl Pediatr. 2024; 13(1):119-136.

PMID: 38323182 PMC: 10839276. DOI: 10.21037/tp-23-596.

References

Peeples E, Genaro-Mattos T . Ferroptosis: A Promising Therapeutic Target for Neonatal Hypoxic-Ischemic Brain Injury. Int J Mol Sci. 2022; 23(13). PMC: 9267109. DOI: 10.3390/ijms23137420. View

Chae J, Kim J, Choi S, Lee S, Ojulari O, Kang Y . Farrerol Induces Cancer Cell Death via ERK Activation in SKOV3 Cells and Attenuates TNF-α-Mediated Lipolysis. Int J Mol Sci. 2021; 22(17). PMC: 8430798. DOI: 10.3390/ijms22179400. View

Lin W, Zhang T, Zheng J, Zhou Y, Lin Z, Fu X . Ferroptosis is Involved in Hypoxic-ischemic Brain Damage in Neonatal Rats. Neuroscience. 2022; 487:131-142. DOI: 10.1016/j.neuroscience.2022.02.013. View

Longa E, Weinstein P, Carlson S, Cummins R . Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989; 20(1):84-91. DOI: 10.1161/01.str.20.1.84. View

Wang X, Wang Y, Huang D, Shi S, Pei C, Wu Y . Astragaloside IV regulates the ferroptosis signaling pathway via the Nrf2/SLC7A11/GPX4 axis to inhibit PM2.5-mediated lung injury in mice. Int Immunopharmacol. 2022; 112:109186. DOI: 10.1016/j.intimp.2022.109186. View

Zeng C, Lin J, Zhang K, Ou H, Shen K, Liu Q . SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/SLC7A11/GPX4 signaling. Cancer Sci. 2022; 113(11):3766-3775. PMC: 9633309. DOI: 10.1111/cas.15531. View

Elias-Miro M, Jimenez-Castro M, Rodes J, Peralta C . Current knowledge on oxidative stress in hepatic ischemia/reperfusion. Free Radic Res. 2013; 47(8):555-68. DOI: 10.3109/10715762.2013.811721. View

Yan C, Zhang X, Miao J, Yuan H, Liu E, Liang T . Farrerol Directly Targets GSK-3 to Activate Nrf2-ARE Pathway and Protect EA.hy926 Cells against Oxidative Stress-Induced Injuries. Oxid Med Cell Longev. 2020; 2020:5967434. PMC: 7007950. DOI: 10.1155/2020/5967434. View

Cui B, Guo X, You Y, Fu R . Farrerol attenuates MPP -induced inflammatory response by TLR4 signaling in a microglia cell line. Phytother Res. 2019; 33(4):1134-1141. DOI: 10.1002/ptr.6307. View

10.

Zeng C, Shao Z, Wei Z, Yao J, Wang W, Yin L . The NOTCH-HES-1 axis is involved in promoting Th22 cell differentiation. Cell Mol Biol Lett. 2021; 26(1):7. PMC: 7901075. DOI: 10.1186/s11658-021-00249-w. View

11.

Zhu K, Zhu X, Sun S, Yang W, Liu S, Tang Z . Inhibition of TLR4 prevents hippocampal hypoxic-ischemic injury by regulating ferroptosis in neonatal rats. Exp Neurol. 2021; 345:113828. DOI: 10.1016/j.expneurol.2021.113828. View

12.

Ma H, Wang X, Zhang W, Li H, Zhao W, Sun J . Melatonin Suppresses Ferroptosis Induced by High Glucose via Activation of the Nrf2/HO-1 Signaling Pathway in Type 2 Diabetic Osteoporosis. Oxid Med Cell Longev. 2020; 2020:9067610. PMC: 7732386. DOI: 10.1155/2020/9067610. View

13.

Fu C, Wu Y, Liu S, Luo C, Lu Y, Liu M . Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway after ischemia. J Ethnopharmacol. 2022; 289:115021. DOI: 10.1016/j.jep.2022.115021. View

14.

Zhao M, Zhu P, Fujino M, Zhuang J, Guo H, Sheikh I . Oxidative Stress in Hypoxic-Ischemic Encephalopathy: Molecular Mechanisms and Therapeutic Strategies. Int J Mol Sci. 2016; 17(12). PMC: 5187878. DOI: 10.3390/ijms17122078. View

15.

Zhang X, Ding M, Zhu P, Huang H, Zhuang Q, Shen J . New Insights into the Nrf-2/HO-1 Signaling Axis and Its Application in Pediatric Respiratory Diseases. Oxid Med Cell Longev. 2019; 2019:3214196. PMC: 6885770. DOI: 10.1155/2019/3214196. View

16.

Niu R, Xiong L, Zhou H, Xue L, Xia Q, Ma Z . Scutellarin ameliorates neonatal hypoxic-ischemic encephalopathy associated with GAP43-dependent signaling pathway. Chin Med. 2021; 16(1):105. PMC: 8524967. DOI: 10.1186/s13020-021-00517-z. View

17.

Greco P, Nencini G, Piva I, Scioscia M, Volta C, Spadaro S . Pathophysiology of hypoxic-ischemic encephalopathy: a review of the past and a view on the future. Acta Neurol Belg. 2020; 120(2):277-288. DOI: 10.1007/s13760-020-01308-3. View

18.

Ma N, Wei Z, Hu J, Gu W, Ci X . Farrerol Ameliorated Cisplatin-Induced Chronic Kidney Disease Through Mitophagy Induction Nrf2/PINK1 Pathway. Front Pharmacol. 2021; 12:768700. PMC: 8631930. DOI: 10.3389/fphar.2021.768700. View

19.

Song S, Han Y, Zhang Y, Ma H, Zhang L, Huo J . Protective role of citric acid against oxidative stress induced by heavy metals in Caenorhabditis elegans. Environ Sci Pollut Res Int. 2019; 26(36):36820-36831. DOI: 10.1007/s11356-019-06853-w. View

20.

Zeng C, Tang H, Chen H, Li M, Xiong D . Ferroptosis: a new approach for immunotherapy. Cell Death Discov. 2020; 6(1):122. PMC: 7665172. DOI: 10.1038/s41420-020-00355-2. View